Read about Minority Health Month and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: Read about Minority Health Month and more
u s food and drug administration
l
office of womens health e-update

April 2017

www.fda.gov/womens

Message from the Director

FDA works in diverse ways to keep women and their families safe.FDA actively promotes health and safety through activities such as soliciting patient feedback on drug development, advancing treatments for women affected by cancer, and monitoring post-market product safety issues.�FDA also provides�safety information in multiple languages and makes Agency resources available on�FDA's For Women, Minority Health and en Espa�/a> webpages.

This Minority Health Month, I encourage you to share the resources in this update to help educate diverse women about the safe use of FDA products. Whether you join one of our campaigns, retweet our messages on Twitter or share a publication in another language, you are showing your commitment to celebrating diversity and encouraging all women to live their healthiest lives.�

Marsha Henderson, Assistant Commissioner for Women�s Health

WOMEN�S HEALTH HIGHLIGHTS

NIH/FDA Pre-Conference Symposium at the Congress on Women�s Health

Please join the NIH Office of Research on Women�s Health and the FDA Office of Women�s Health on April 27, 2017 from 2:30 � 5 p.m. for a pre-conference symposium entitled �Working Together to Address Women�s Health in Research and Drug Development: Challenges and Opportunities.��Presentations will address the inclusion of women in clinical trials, precision medicine, and the Women�s Health Initiative. There is no charge to attend the pre-conference Symposium, but seats are limited.�

If you are attending the full Congress on Women�s Health, please also visit OWH�s poster presentation on the demographics of study participants in clinical trials for oncology drugs approved by FDA CDER from January to November 10, 2016.�

Minority Health Month Resources

Throughout April, share healthy living tips to educate and empower women from diverse cultural backgrounds to make their health a priority.

FDA approves maintenance treatment for certain recurrent cancers affecting women

FDA approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

Read the Press Release

Extras

Irritable Bowel Syndrome (IBS) Awareness�

Irritable bowel syndrome (IBS) is an often misunderstood and underdiagnosed condition that affects about 15.3 million people in the United States.�Women have a higher prevalence of IBS.�

Read this consumer update to learn the facts about IBS and what FDA is doing to keep you safe.

Read the Consumer Update

Meetings

Participate in upcoming FDA Public Meetings.

Battery Safety Concerns in Electronic Nicotine Delivery Systems (ENDS) Public Workshop

April 19 - 20, 2017, 8:30 am to 4:30 pm

FDA White Oak Campus, Silver Spring, MD

Public Meeting: Patient Focused Drug Development Meeting � Autism

May 4, 2017, 1:00 pm to 5:00 pm

FDA White Oak Campus - Silver Spring, MD

Public Workshop: Roadmap for Engaging With the Food and Drug Administration's Center for Drug Evaluation and Research

May 12, 2017, 9:00 am to 3:00 pm

FDA White Oak Campus - Silver Spring, MD

Visit an OWH exhibit booth or presentation at these upcoming conferences.

Annual Congress on Women�s Health

April 28 � 30, 2017, Washington, DC

Association of Clinical Research Professionals

April 29 � May 2, 2017, Seattle, WA

The American College of Obstetricians and Gynecologists (ACOG)

May 6-9, 2017, San Diego, CA

Learn more about OWH staff presentations at national and international meetings and conferences.�


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) � 10903 New Hampshire Ave � Silver Spring, MD 20993 � 1-888-INFO-FDA (1-888-463-6332) Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux